You are viewing: China Endoscopic Submucosal Dissection/ESD Market analysis

The China Endoscopic Submucosal Dissection/ESD Market was valued at $19.4 Million in 2025 and projected to reach to $31.4 Million by 2030, representing a compound annual growth rate of 10.1%. China's Endoscopic Submucosal Dissection market is positioned for sustained growth through 2030, driven by rising gastrointestinal disease burden, aging demographics, and government healthcare modernization initiatives.

China Endoscopic Submucosal Dissection/ESD Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

China Endoscopic Submucosal Dissection/ESD Market Trends and Insights

  • This represents a compound annual growth rate (CAGR) of 10.1%, significantly outpacing global market growth.
  • China's rapid adoption of minimally invasive endoscopic techniques is driven by increasing prevalence of gastrointestinal malignancies, rising healthcare expenditure, and growing awareness of early cancer detection among the Chinese population. The Chinese market benefits from substantial government investment in healthcare infrastructure and a shift toward advanced diagnostic and therapeutic endoscopy.
  • China's large patient base and expanding middle class are fueling demand for sophisticated ESD procedures as alternatives to traditional surgical interventions.
  • Between 2025 and 2030, China is expected to consolidate its position as a key growth engine within the Asia Pacific region, supported by improving reimbursement policies and the proliferation of specialized endoscopy centers across major urban and emerging markets..

Key Market Statistics

  • CAGR (2025-2030) 10.1% CAGR
  • Market Size, 2025 ~USD 19.4 Million
  • Forecast, 2030 ~USD 31.4 Million
  • Country China

China Endoscopic Submucosal Dissection/ESD Market Overview

Rapid Market Expansion :

China's ESD market is growing at 10.1% CAGR, significantly outpacing the global rate of 8.4%, reflecting accelerating adoption of minimally invasive endoscopic procedures across Chinese healthcare facilities.

Rising GI Disease Prevalence :

Increasing incidence of gastrointestinal cancers and precancerous lesions in China is driving demand for advanced endoscopic treatment options, positioning ESD as a critical therapeutic solution.

Healthcare Infrastructure Investment :

China's substantial investments in modernizing hospital endoscopy departments and training specialized physicians are enabling wider ESD adoption across tier-1, tier-2, and emerging tier-3 cities.

Market Valuation Growth :

The Chinese ESD market is valued at USD 19.4 million in 2025 and is forecast to reach USD 31.4 million by 2030, representing a 62% increase over the five-year projection period.

China Endoscopic Submucosal Dissection/ESD Market Dynamics

  • The 10.1% CAGR reflects strong institutional adoption of ESD technology in major urban centers and expanding access to specialized endoscopy training programs.
  • Increasing awareness among Chinese physicians regarding ESD's superior efficacy compared to traditional resection methods is accelerating clinical adoption. Looking ahead, market expansion will be supported by growing healthcare expenditure, rising patient demand for minimally invasive treatments, and continued development of domestic ESD device manufacturing capabilities.
  • Strategic partnerships between international medical device companies and Chinese hospitals, combined with regulatory streamlining for advanced endoscopic technologies, will further accelerate market penetration across secondary and tertiary care facilities throughout China..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • JOHNSON & JOHNSON

    Key Takeaways

    • China's ESD market is valued at USD 19.4 million in 2025 and will grow to USD 31.4 million by 2030, driven by a 10.1% CAGR.
    • Rising gastrointestinal cancer incidence and early detection initiatives are accelerating ESD adoption across China's healthcare system.
    • China's expanding healthcare infrastructure and improving reimbursement policies are creating favorable conditions for ESD procedure growth.
    • China is positioned as the fastest-growing ESD market in Asia Pacific, outpacing the global average growth rate of 8.4%.

    Endoscopic Submucosal Dissection/ESD Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment KNIVES (Product)
    Forecast Period 2025–2030
    Growth Rate CAGR of 8.4% from 2025 to 2030
    Largest Segment GASTROSCOPES & COLONOSCOPES (Product)
    Market Size Base Year (Billions) ~USD 0.5 (2025)
    Revenue Forecast (Billions) ~USD 0.75 (2030)
    Segments Covered Product, Indication, End User

    China Endoscopic Submucosal Dissection/ESD Market Report Segmentation

    3 segment dimensions are covered across the global market.

    By Product

    • Gastroscopes & Colonoscopes
    • Grasp/Clips
    • Graspers/Clips
    • Injection Agents
    • Knives
    • Other Products
    • Tissue Retractors

    By Indication

    • Colon Cancer
    • Esophageal Cancer
    • Stomach Cancer

    By End User

    • Ambulatory Surgical Centers
    • Hospitals
    • Other End Users
    • Specialty Clinics

    CHINA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2023–2030

    Segment20232024202520262027202820292030CAGR (%)
    AMBULATORY SURGICAL CENTERS5.986.477.27.868.679.5510.4911.559.9
    HOSPITALS21.0722.8725.5528.0131.0234.3337.8841.8710.4
    OTHER END USERS1.031.11.211.311.421.551.681.838.6
    SPECIALTY CLINICS6.997.548.379.1110.0211.0112.0613.249.6
    TOTAL35.0837.9842.3346.2951.1356.4362.1168.4910.1

    Target Audience

    • Medical Device Manufacturers : ESD equipment and accessory producers need China-specific market data to assess market size, growth potential, competitive positioning, and distribution channel strategies for product launches and expansion.
    • Healthcare Investment Firms : Private equity and venture capital investors require validated market metrics, growth forecasts, and China healthcare trends to evaluate investment opportunities in endoscopy companies and hospital networks.
    • Hospital & Clinic Operators : Chinese healthcare facility administrators need market intelligence on ESD demand, patient volumes, reimbursement rates, and technology adoption benchmarks to justify capital investments in endoscopy departments.
    • Pharmaceutical & Biotech Companies : Organizations developing adjunctive therapies or diagnostic tools for GI conditions require China market data to understand ESD adoption rates and identify complementary product opportunities.
    • Healthcare Consultants & Analysts : Strategy consultants and market research professionals need comprehensive China ESD market data to support client advisory work, competitive analysis, and market entry recommendations.

    Key Companies in the China Endoscopic Submucosal Dissection/ESD Market

    CompanyHQOwnershipStrongest segments
    OLYMPUS CORPORATIONJapanPublic CompanyGastrointestinal Solutions,Urology,Respiratory,
    MEDTRONICIrelandPublic CompanyCardiovascular Portfolio,Neuroscience Portfolio,Medical Surgical Portfolio (incl. Diabetes),
    FUJIFILM HOLDINGS CORPORATIONJapanPublic CompanyHealthcare (medical systems, CDMO, pharma, regenerative medicine, cosmetics/supplements),Electronics (display/touch, semiconductor and image sensor materials, storage/archiving, industrial equipment, fine chemicals),Business Innovation (office equipment, document solutions, graphic communications, inkjet heads),
    BOSTON SCIENTIFIC CORPORATIONUnited StatesPublic CompanyCardiovascular (structural heart, CRM, peripheral interventions, oncology),MedSurg – Endoscopy (GI, pancreaticobiliary, infection prevention, single-use scopes),MedSurg – Urology and Pelvic Health,
    SUMITOMO BAKELITE CO., LTD.JapanPublic CompanySemiconductor encapsulation and substrate materials,Phenolic molding compounds and industrial resins,Copper-clad laminates (phenolic and epoxy),
    CREO MEDICAL GROUP PLCUnited KingdomPublic CompanyCROMA platform and capital equipment,Speedboat Inject and multimodal endoscopic instruments,MicroBlate Fine and MicroBlate Flex ablation devices,
    HOYA CORPORATIONJapanPublic CompanyEyeglasses and ophthalmic lenses,Contact lenses and Eyecity retail,Intraocular lenses and surgical ophthalmology,
    CONMED CORPORATIONUnited StatesPublic CompanyOrthopedic & Sports Medicine (BioBrace, Y-Knot, TruShot, Hall power tools),General Surgery (AirSeal insufflation, Buffalo Filter smoke, endomechanical),Endoscopic Technologies (GI therapeutic and diagnostic),
    STERISIrelandPublic CompanyHealthcare sterilization and washer-disinfectors,Endoscope reprocessing systems and consumables,Operating room equipment and integration,

    OLYMPUS CORPORATION

    Olympus Corporation is a Japanese public company founded in 1919 with 28,138 employees. The company operates as a diversified manufacturer with significant operations in medical devices and imaging technology.

    MEDTRONIC

    Medtronic is a public company headquartered in Ireland, founded in 1949, with approximately 95,000 employees. It is a global leader in medical technology, services, and solutions.

    FUJIFILM HOLDINGS CORPORATION

    Fujifilm Holdings Corporation is a Japanese public company established in 1934 with 73,526 employees. The company operates across imaging, information, and document solutions, as well as healthcare and materials sectors.

    BOSTON SCIENTIFIC CORPORATION

    Boston Scientific Corporation is a United States-based public company founded in 1979 with 59,000 employees. It specializes in the development and manufacture of medical devices and technologies.

    SUMITOMO BAKELITE CO., LTD.

    Sumitomo Bakelite Co., Ltd. is a Japanese public company founded in 1932 with 7,524 employees. The company manufactures advanced materials and components for various industrial applications.

    CREO MEDICAL GROUP PLC

    Creo Medical Group PLC is a United Kingdom-based public company founded in 2003 with 104 employees. The company develops and commercializes medical devices and technologies.

    HOYA CORPORATION

    Hoya Corporation is a Japanese public company established in 1941 with 37,752 employees. The company manufactures optical products, medical devices, and precision equipment.

    CONMED CORPORATION

    CONMED Corporation is a United States-based public company founded in 1970 with 3,900 employees. The company designs, manufactures, and sells medical devices and equipment for surgical and patient monitoring applications.

    STERIS

    STERIS is a public company headquartered in Ireland, founded in 1985. The company provides sterilization and contamination control products and services for healthcare and industrial markets.

    Reasons to Buy this Report

    • Market Size & Growth Validation : Obtain precise valuation data for China's ESD market (USD 19.4M in 2025) with verified 10.1% CAGR projections through 2030, enabling accurate financial forecasting and investment decision-making.
    • Competitive Landscape Intelligence : Understand China-specific market dynamics, key players, regional adoption patterns, and competitive positioning to develop targeted market entry or expansion strategies in this high-growth segment.
    • Regulatory & Reimbursement Insights : Access detailed analysis of China's healthcare policies, medical device regulations, insurance coverage for ESD procedures, and government initiatives affecting market accessibility and profitability.
    • Clinical Adoption Trends : Identify adoption rates across Chinese hospital tiers, physician training gaps, technology preferences, and barriers to ESD implementation to optimize product positioning and sales strategies.
    • Investment & Partnership Opportunities : Discover high-potential collaboration opportunities with Chinese healthcare providers, distributors, and manufacturers, supported by market data validating the 62% growth opportunity through 2030.

    Frequently asked questions

    What is the current market size of ESD in China?

    China's ESD market was valued at USD 19.4 million in 2025 and is expected to reach USD 31.4 million by 2030.

    What is the projected growth rate for China's ESD market?

    China's ESD market is projected to grow at a compound annual growth rate (CAGR) of 10.1% from 2025 to 2030.

    What factors are driving ESD market growth in China?

    Key drivers include rising gastrointestinal cancer prevalence, increased healthcare spending, government investment in endoscopy infrastructure, and growing patient awareness of minimally invasive treatment options.

    How does China's ESD market compare to global growth?

    China's ESD market is growing at 10.1% CAGR, which exceeds the global market CAGR of 8.4%, positioning China as a high-growth region.

    What is the forecast market size for China's ESD market in 2030?

    China's ESD market is forecasted to reach USD 31.4 million by 2030, representing significant expansion from the 2025 baseline.

    RESEARCH METHODOLOGY

    The study focused on estimating the current size of the endoscopic submucosal dissection (ESD) market. We conducted thorough secondary research to gather information about the market. The next step involved validating our findings, assumptions, and estimates through primary research by consulting industry experts throughout the value chain. We used various approaches, including top-down and bottom-up methods, to calculate the total market size. Subsequently, we applied market breakdown and data triangulation techniques to estimate the sizes of different segments and subsegments within the ESD market.

    Secondary Research

    This research study heavily utilized secondary sources, including directories and databases such as Dun & Bradstreet, Bloomberg Businessweek, Factiva, whitepapers, and company documents. The purpose of the secondary research was to identify and gather information for a comprehensive, technical, market-oriented, and commercial analysis of the endoscopic submucosal dissection (ESD) market. It also aimed to collect vital information about leading industry players, market classification, and segmentation according to industry trends, down to the most granular levels, as well as geographic markets and key developments related to the market. Additionally, a database of key industry leaders was created based on the findings from the secondary research.

    Primary Research

    During the primary research process, a variety of supply-side and demand-side sources were interviewed to gather both qualitative and quantitative information for this report. On the supply side, primary sources included industry experts such as CEOs, vice presidents, marketing and sales directors, technology and innovation directors, engineers, and other key executives from various companies and organizations operating in the ESD market. On the demand side, primary sources encompassed hospitals, clinics, researchers, lab technicians, purchasing managers, and stakeholders from corporate and government bodies.

    Breakdown of Primary Interviews

    Endoscopic Submucosal Dissection Market

    Note 1: C-level executives include CEOs, COOs, and CTOs.

    Note 2: Others include sales, marketing, and product managers.

    Note 3: Companies are classified into tiers based on their total revenue. As of 2024: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the total size of the ESD market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    Endoscopic Submucosal Dissection Market

    Data Triangulation

    The entire market was split into three segments when the market size was determined. Data triangulation and market breakdown processes were used where necessary to complete the entire market engineering process and arrive at precise statistics for all segments.

    Approach to derive the market size and estimate market growth.

    Using secondary data from paid and unpaid sources, the market rankings for the major players were determined following a thorough analysis of their sales of ESD. Due to data restrictions, the revenue share in certain cases was determined after a thorough analysis of the product portfolio of big corporations and their individual sales performance. This information was verified at each stage by in-depth interviews with professionals in the field.

    Market Definition

    Endoscopic submucosal dissection (ESD) is an advanced therapeutic endoscopy technique for superficial gastrointestinal neoplasms. In endoscopic submucosal dissection, the equipment includes different types of knives, forceps, snares, and a few other products that support the procedure, as well as accessories used to ease the handling of instruments during surgeries.

    Stakeholders

    • Manufacturers of endoscopes and related devices
    • Suppliers and distributors of endoscopy devices
    • Hospitals, diagnostic centers, and medical colleges
    • Independent surgeons and private offices of physicians
    • Ambulatory surgery centers (ASCs)
    • Teaching hospitals and academic medical centers
    • Government bodies/municipal corporations
    • Business research and consulting service providers
    • Venture capitalists
    • US Food and Drug Administration (US FDA)
    • European Union (EU)

    Report Objectives

    • To define, describe, and forecast the endoscopic submucosal dissection market by product, indication, end user, and region
    • To provide detailed information regarding the major factors influencing the market growth (drivers, restraints, opportunities, and challenges)
    • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall endoscopic submucosal dissection market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the endoscopic submucosal dissection market in six regions: North America (US and Canada), Europe (Germany, the UK, France, Spain, Italy, and the Rest of Europe), the Asia Pacific (Japan, China, India, Australia, South Korea, and the Rest of Asia Pacific), Latin America (Brazil, Mexico, and the Rest of Latin America), the Middle East & Africa, and the GCC Countries
    • To strategically profile the key players in the global market and comprehensively analyze their core competencies
    • To track and analyze competitive developments, such as product launches, expansions, agreements, and acquisitions, of the leading players in the market

    Get the Full Endoscopic Submucosal Dissection/ESD Market Report

    Full forecast, segment splits, and company analysis for all Endoscopic Submucosal Dissection/ESD Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status